Ellen M. Zane
Sits on 5 boards. Overboarded · 5 public boards Last updated September 27, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 5 boards, counting each seat separately. Longest: Synchrony Financial, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Haemonetics Corporation July 24, 202697.4%
-
Synchrony Financial June 24, 202699.6%
-
Boston Scientific Corporation April 30, 202695.3%
-
Haemonetics Corporation July 24, 202598.2%
-
Synchrony Financial June 17, 202599.0%
-
Boston Scientific Corporation May 1, 202597.0%
-
Haemonetics Corporation July 25, 202498.5%
-
Synchrony Financial June 11, 202498.7%
-
Boston Scientific Corporation May 2, 202497.5%
-
Haemonetics Corporation August 4, 202384.8%
-
Synchrony Financial May 18, 202392.1%
-
Boston Scientific Corporation May 4, 202386.7%
-
Azenta Inc. January 31, 202393.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Synchrony Financial | Grant or award | +14 | $80.75 | $1,131 |
| Jul 24, 2026 | Haemonetics Corporation | Grant or award | +2,538 | — | — |
| Jun 30, 2026 | Synchrony Financial | Grant or award | +789 | $76.05 | $60,003 |
| May 15, 2026 | Synchrony Financial | Grant or award | +14 | $71.38 | $999 |
| May 7, 2026 | Boston Scientific Corporation | Grant or award | +3,800 | — | — |
| Mar 31, 2026 | Synchrony Financial | Grant or award | +883 | $68.02 | $60,062 |
| Feb 17, 2026 | Synchrony Financial | Grant or award | +14 | $72.31 | $1,012 |
| Dec 31, 2025 | Synchrony Financial | Grant or award | +660 | $83.43 | $55,064 |
| Nov 17, 2025 | Synchrony Financial | Grant or award | +15 | $70.47 | $1,057 |
| Nov 6, 2025 | Boston Scientific Corporation | Open-market sale | −12,891 | $98.28 | $1,266,927 |
| Oct 29, 2025 | Boston Scientific Corporation | Other | +12,891 | — | — |
| Oct 28, 2025 | Boston Scientific Corporation | Open-market sale | −2,901 | $102.24 | $296,598 |
| Oct 27, 2025 | Boston Scientific Corporation | Open-market sale | −9,990 | $101.13 | $1,010,289 |
| Sep 30, 2025 | Synchrony Financial | Grant or award | +775 | $71.05 | $55,064 |
| Aug 15, 2025 | Synchrony Financial | Grant or award | +15 | $71.49 | $1,072 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.